These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of the multidrug resistance efflux pump. Wigler PW; Patterson FK Biochim Biophys Acta; 1993 Oct; 1154(2):173-81. PubMed ID: 8105892 [TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in human cancer. Goldstein LJ; Pastan I; Gottesman MM Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966 [No Abstract] [Full Text] [Related]
7. Reversal of multidrug resistance by RU 486. Gruol DJ; Zee MC; Trotter J; Bourgeois S Cancer Res; 1994 Jun; 54(12):3088-91. PubMed ID: 7911394 [TBL] [Abstract][Full Text] [Related]
8. Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Wigler PW; Patterson FK Biochim Biophys Acta; 1994 Jan; 1189(1):1-6. PubMed ID: 7905747 [TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells. Safa AR Cancer Invest; 1993; 11(1):46-56. PubMed ID: 8093677 [No Abstract] [Full Text] [Related]
10. Multidrug resistance and P-glycoprotein expression. Ling V Ann N Y Acad Sci; 1987; 507():7-8. PubMed ID: 2894794 [No Abstract] [Full Text] [Related]
11. The role of P-glycoprotein in drug-resistant hematologic malignancies. Dalton WS; Grogan TM; Miller TP Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717 [No Abstract] [Full Text] [Related]
12. Multidrug resistance: a novel class of membrane-associated transport proteins is identified. Gros P; Shustik C Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020 [No Abstract] [Full Text] [Related]
17. P glycoprotein (P-gp) and drug resistance--time for reappraisal? Kaye SB Br J Cancer; 1993 Apr; 67(4):641-3. PubMed ID: 8097103 [No Abstract] [Full Text] [Related]
18. Antineoplastic drug resistance and breast cancer. Morrow CS; Cowan KH Ann N Y Acad Sci; 1993 Nov; 698():289-312. PubMed ID: 7904140 [No Abstract] [Full Text] [Related]